A Study of ZL-1310 in Participants With Selected Solid Tumors

Part of paid clinical trials in San Francisco, California.

Sponsor
Zai Lab (Shanghai) Co., Ltd.
Study ID
NCT06885281
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Solid Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Key Dates

First listed
Mar 20, 2025
Start date
May 12, 2025
Status verified
Jun 2026
Primary completion
Aug 31, 2027
Completion
Apr 30, 2028

Study Design

Enrollment
166 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Single Arm
    ZL-1310 as a single agent

Primary Outcome Measure

Incidence of Treatment Emergent Adverse-Events in Phase 1b [ Time Frame: up to 36 months ]

Central Contacts

Locations (12)

FacilityCityStateZIPSite coordinators
University of California San Francisco/Helen Diller Family Comprehensive Cancer CenterSan FranciscoCalifornia94143-
OSF St. Francis Medical CenterPeoriaIllinois61637-
Karmanos Cancer CenterDetroitMichigan48201-
Memorial Sloan-Kettering Cancer CenterNew YorkNew York10065-
University Hospitals Cleveland Medical CenterClevelandOhio44106-
Fox Chase Cancer CenterPhiladelphiaPennsylvania19111-
SCRI OP (Oncology Partners)NashvilleTennessee37203-
Texas Oncology / Sammons Cancer CenterDallasTexas75246-
The University of Texas M. D. Anderson Cancer CenterHoustonTexas77030-
Texas Oncology - Central SouthMcAllenTexas78503-
Virginia Cancer SpecialistsFairfaxVirginia22031-
Virginia Oncology AssociatesNorfolkVirginia23502-

Find similar trials in San Francisco, CA

By research site
University of California San Francisco/Helen Diller Family Comprehensive Cancer Center· San Francisco, CAOSF St. Francis Medical Center· Peoria, ILKarmanos Cancer Center· Detroit, MIMemorial Sloan-Kettering Cancer Center· New York, NYUniversity Hospitals Cleveland Medical Center· Cleveland, OHFox Chase Cancer Center· Philadelphia, PA

Related Studies